首頁 產業/市場分類 出版商一覽 Email 通知 GII媒體代理會議 公司簡介 聯絡我們
- English Japanese Korean
首頁 > 市場調查報告書 > 生物科技 > 以基因為基之藥物開發 > 聚合酶鏈鎖反應(PCR):產品/工具 - 全球市場趨勢(2009∼2015年)
產業/市場分類
生物科技 (1574)
分子標靶治療學 (131)
生技設備 (354)
生物材料 (53)
生物標記 (155)
以基因為基之藥物開發 (202)
再生醫學 (119)
抗體和免疫 (189)
個人化醫學 (51)
基因治療學和RNAi (102)
市場調查報告書

聚合酶鏈鎖反應(PCR):產品/工具 - 全球市場趨勢(2009∼2015年)

Polymerase Chain Reaction (PCR) - Products/Tools - A Global Market Watch, 2009-2015

出版商 Axis Research Mind
出版日期 2011年11月 商品編碼 223423
內容資訊 英文 342 Pages
價格
US $ 3450 PDF by E-mail (Single User License)
US $ 5550 PDF by E-mail (Enterprisewide License)


聚合酶鏈鎖反應(PCR):產品/工具 - 全球市場趨勢(2009∼2015年) 是由出版商Axis Research Mind在2011年11月所出版的。 這份英文市場調查報告書包含342 Pages 價格從美金3450起跳。

簡介

全球的PCR市場預測到2015年為止將達到接近274億美金的規模。一般預計2009∼2015年的GAGR為13.9%。北美以最大市場自豪,在2010年末的現在佔全球總市場的40%,為107億美金。歐洲及亞太地區則合佔全球佔有率的50%,此外,南美洲則以14.8%的GAGR,為發展最快速的地區,預計到2015年將達到接近13億美金的規模。

本報告提供聚合酶鏈鎖反應(PCR)市場趨勢與未來發展預測相關分析,彙整各不同產品/工具市場規模,參與企業的投資策略等,為您概述為以下內容。

第1章 本報告焦點

  • 簡介
    • 聚合酶鏈鎖反應定義
    • 聚合酶鏈鎖反應的範圍
    • 聚合酶鏈鎖反應的歷史
    • 聚合酶鏈鎖反應的變化
    • 聚合酶鏈鎖反應的優點和缺點
    • 聚合酶鏈鎖反應的最佳化
    • 熱循環
    • 聚合酶鏈鎖反應的階段
    • PCR成功的指標
    • 熱循環相關考察
    • 聚合酶鏈鎖反應的理論與手法
    • PCR:核酸檢驗的改善技術
    • 臨床檢測上的聚合酶鏈鎖反應
  • 聚合酶鏈鎖反應(PCR)的產品/工具
    • 機器
    • 試劑
    • 消耗品
    • 其他
    • PCR化驗
    • PCR化驗的必要性
    • 化驗相關考察
    • 聚合酶鏈鎖反應的各地區市場趨勢
      • 北美
      • 歐洲
      • 亞太地區
      • 南美及其他

第2章 市場分析

  • 聚合酶鏈鎖反應(PCR):產品/工具-產業概要
  • 全球
  • 各國分析
  • 各不同產品/工具
    • 機器
    • 試劑
    • 消耗品
    • 其他
  • 成長率分析
  • 投資對象

第3章 產業概要

  • 產業活動
    • 合併·收購·合作·專利·合資企業
  • 市場趨勢
  • 產業領導者
  • 今後預測
  • 企業簡介

第4章 產業企業資料庫

第5章 附錄

目錄

Abstract

REPORT DESCRIPTION

Global Market Watch:

The global PCR market is projected to reach around US$27.4 billion by 2015, with a Compounded Annual Growth Rate (CAGR) of 13.9% for the analysis period, 2009-2015. North America is estimated as the largest market with a market share of 40% of global market and projects US$10.7 billion by end-2010. Europe and Asia-Pacific together account for more than 50% of the global market share. Interestingly, Latin America is seen as the fastest growing market with a CAGR of 14.8%, to worth around US$1.3 billion in 2015.

Based on the classification by products/tools, PCR Reagents are expected to be fastest growing market with a CAGR of 14.6%. PCR Consumables and PCR Machines are expected grow with a CAGR of 14.2% and 13.1% respectively.

KEY INDUSTRY ACTIVITIES

  • GENEWORKS CHAINS THE HUMAN MITOCHONDRIAL TRANSCRIPTOME
  • EPPENDORF GETS LICENSES TECHNOLOGY FOR THERMAL CYCLERS TO BULLDOG BIO
  • CALIPER LAUNCHES ZEPHYR NGS POST-PCR WORKSTATION
  • HKSH SELECTS GE HEALTHCARE'S PET/CT+MR FOR MANAGEMENT OF DISEASES
  • ABBOTT INTRODUCES ALK GENETIC TEST FOR NSCLC
  • QIAGEN ACQUIRES CELLESTIS
  • ABBOTT OBTAINS FDA APPROVAL FOR ALK GENE TEST
  • BIONEER RELEASES H1N1 VIRUS DIAGNOSTIC KIT
  • COMPLETE GENOMICS TO SEQUENCE DNA FOR NCI'S PEDIATRIC CANCER STUDY
  • ABBOTT GETS FDA CLEARANCE FOR VYSIS CLL FISH PROBE KIT
  • ABBOTT ANNOUNCES SUCCESSFUL TREATMENT OF THE FIRST PATIENT IN JAPAN WITH ABSORB™ BIORESORBABLE VASCULAR SCAFFOLD
  • QIAGEN AND PFIZER ANNOUNCE PARTNERSHIP
  • ABBOTT GETS FDA APPROVAL FOR RX HERCULINK ELITER RENAL STENT SYSTEM
  • ABBOTT INTRODUCES PLEX-ID™ VECTOR-BORNE TEST
  • BIOGEN IDEC AND ABBOTT ANNOUNCE SUCCESS OF SELECT TRIAL FOR RRMS
  • QIAGEN INAUGURATES TAIWAN SUBSIDIARY IN TAIPEI
  • QIAGEN COMPLETES SECOND U.S. SUBMISSION FOR THERASCREENR KRAS RGQ PCR KIT
  • ILLUMINA AND THE UNIVERSITY OF OXFORD COLLABORATE FOR PERSONALIZED MEDICINE
  • BD SIGNS AGREEMENT TO ACQUIRE CARMEL PHARMA
  • STARTING UP THE GENE THERAPY PROJECT IN CHINA
  • PROMEGAPOWERPLEXR 18D SYSTEM OBTAINS NDIS APPROVAL FOR OFFENDER DNA PROFILING
  • AFFYMETRIX STARTS SHIPMENT OF GENE PROFILING REAGENTS
  • LIFE TECHNOLOGIES INTRODUCES APPLIED BIOSYSTEMSVETMAXTM-GOLD SIV DETECTION KIT
  • BIOTAGE INTRODUCES MICROWAVE PEPTIDE SYNTHESIZER
  • RAISING THE BAR IN MICROWAVE SYNTHESIS BY BIOTAGE
  • COMPLETE GENOMICS INTRODUCES CANCER GRANT PROGRAM
  • PROMEGA INTRODUCES BIOLUMINESCENT HDAC ASSAYS
  • QIAGEN PREPARES PROPOSAL TO FULLY ACQUIRE IPSOGEN
  • ABBOTT OBTAINS CE MARK FOR ITS REAL TIME PCR TEST FOR CMV
  • & many more....

“Learn High Potential Market Dynamics for Strategic Business Planning”

Report Focus:

The report “Polymerase Chain Reaction (PCR): Products/Tools - A Global Market Watch, 2009-2015” reviews the latest PCR market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations.

The report primarily focuses on:

  • Emerging market trends
  • Advancements in the technological space
  • Market demand of the segments (by-region)
  • Key growth areas and market size
  • Key competitor's Edge

The analysis primarily deals with major PCR product/tools market.

Further, the subdivided categories include:

  • PCR Product/Tools
  • PCR Machines
  • PCR Reagents
  • PCR Consumables
  • Other (Software, Pipetting Robot & etc.,)

The period considered for the PCR market analysis is 2009-2015. The region wise distribution of the market consists of North America (USA and Canada), Europe (France, Germany, United Kingdom, Italy, Spain and Rest of Europe), Asia- Pacific (Japan, China, India, Korea and Rest of Asia-Pacific), Latin America (Brazil, Columbia, Argentina and Rest of Latin America) and Rest of the World. Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.

More than 810 leading market players are identified and 53 key companies that project improved market activities in the near future are profiled. The report consists of 117 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

The broad ‘life science&rlsquo; division has been witnessing a rapid growth and technological improvements varying from sector to sector since the past 3-5 years. Accelerating growth rate exhibited by the PCR industry, even during the recession years, confirms the positive growth prospects going ahead. Among the major developments in the recent years, gene amplification technology indicates the highest potential growth. Molecular diagnostics and the Human Genome Project (HGP) are two of the main drivers that contribute to the growth of gene amplification technology. It covers all segments such as drug discovery, DNA amplification, forensic identification, gene therapy and diagnosis. Freshly developed PCR Instruments for detecting most of the life threatening diseases also signal positive demand growth. Among the PCR types, q-PCR is expected witness the largest CAGR during 2009-2015.

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the PCR industry. Anticipated of protracted economic recovery towards to 2011, we have used CAGR to forecasts to 2011 till 2015.

GEOGRAPHIC COVERAGE

Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan and China along with the other emerging countries are estimated individually for the upcoming years. Anticipating a protracted economic recovery towards to 2011 and based on the CAGR estimates and growth potential, we have forecasted the market size figures for the next five years.

The region wise distribution of the market consists of North America, Europe, Asia-Pacific, Latin America and Rest of World with 14 countries, analyzed individually as follows:

  • NORTH AMERICA: USA & CANADA
  • EUROPE: FRANCE, GERMANY, UNITED KINGDOM, ITALY, SPAIN AND REST OF EUROPE
  • ASIA-PACIFIC: JAPAN, CHINA, INDIA, KOREA AND REST OF ASIA-PACIFIC
  • LATIN AMERICA: BRAZIL, COLUMBIA, ARGENTINA AND REST OF LATIN AMERICA &
  • REST OF THE WORLD
  • -

Table of Contents

I. REPORT FOCUS

  • PRODUCT/TOOLS IN PCR

A. INTRODUCTION

  • DEFINING POLYMERASE CHAIN REACTION
  • SCOPE OF POLYMERASE CHAIN REACTION
  • HISTORY OF POLYMERASE CHAIN REACTION
  • VARIATIONS OF POLYMERASE CHAIN REACTION
    • ALLELE-PRECISE PCR
    • PCA (POLYMERASE CYCLING ASSEMBLY) OR ASSEMBLY PCR
    • ASYMMETRIC PCR
    • HELICASE-RELIANT AMPLIFICATION
    • HOT - START PCR
    • INTERSEQUENCE-SPECIFIC PCR
    • REVERSE PCR
    • LIGATION MEDIATED PCR
    • METHYLATION SPECIFIC PCR
    • MINIPRIMER PCR
    • MULTIPLEX LIGATION-RELIANT PROBE AMPLIFICATION
    • MULTIPLEX PCR
    • NESTED PCR
    • OVERLAP-EXTENSION PCR
    • QUANTITATIVE PCR
    • RT-PCR
    • SOLID-PHASE PCR
    • TAIL-PCR
    • TOUCHDOWN PCR
    • PAN-AC
    • UNIVERSAL FAST WALKING
  • MERITS & DEMERITS OF POLYMERASE CHAIN REACTION
  • OPTIMIZING POLYMERASE CHAIN REACTION
  • THERMAL CYCLERS (POLYMERASE CHAIN REACTION)
  • PHASES OF POLYMERASE CHAIN REACTION
  • PARAMETERS FOR SUCCESSFUL PCR
    • I) METAL ION COFACTORS AND PCR
    • II) SUBSTRATES AND SUBSTRATE ANALOGS FOR PCR
    • III) BUFFERS AND SALTS FOR PCR
    • IV) COSOLVENTS
  • THERMAL CYCLING CONSIDERATIONS
    • I) PCR VESSELS
    • II) TEMPERATURE AND CYCLE TIME OPTIMIZATION
    • III) PCR AMPLIFICATION CYCLE NUMBER
    • IV) ENZYME / TARGET
    • V) HOT START CONDITIONS
  • THEORY AND METHODOLOGY OF POLYMERASE CHAIN REACTION
    • METHODOLOGY OF USE
  • PCR - IMPROVISED TECHNIQUE FOR TESTING NUCLEIC ACIDS
  • FINAL ELONGATION
  • POLYMERASE CHAIN REACTION IN CLINICAL DETECTIONS

B. PRODUCT/TOOLS IN POLYMERASE CHAIN REACTION (PCR)

  • PCR MACHINES
    • REAL-TIME PCR MACHINES
    • REAL-TIME PCR INSTRUMENTATION
  • PCR REAGENTS
    • ROLE OF PCR REAGENTS
    • GOTAQR PCR MIX
    • PRIMERS
    • NEXT GENERATION PCR REAGENTS FOR CLINICAL DIAGNOSTICS
    • PCR REAGENT MARKET TRENDS
    • DNA TEMPLATE
  • PCR CONSUMABLES
  • OTHER
    • PCR SOFTWARE
    • PCR ROBOTICS
    • THE AUTOMATION AND USAGE OF ROBOTICS IN AMPLIFICATION ASSAYS
    • PRE-PCR ROBOTIC SYSTEM
    • THE POST-PCR ROBOTIC SYSTEM
    • INTEGRATED ROBOTIC SYSTEM FOR HIGH SAMPLE THROUGHPUT WITHIN A DNA DATABASING UNIT
  • PCR ARRAYS
  • NEED OF PCR ARRAYS
    • DOCTRINE OF ASSAY CORROBORATION FOR NUCLEIC ACID DIAGNOSTIC TESTS
  • ASSAY CORROBORATION - AN INTRODUCTION
    • SELECTING AN ASSAY FITTING ITS INTENDED PURPOSE
  • CONSIDERATIONS TOWARDS PRIMITIVE ASSAY DEVELOPMENTS
    • A) CARE AND RESTRAINTS
    • B) PROTECTIONS FOR AVOIDING FALSE-POSITIVE RESULTS
    • C) SAFEGUARDS FOR AVOIDING NEGATIVE OUTCOMES
    • D) STANDARDS' PREPARATION
  • ASSAY CORROBORATION - PART I
    • 1. REAGENTS' OPTIMIZATION BESIDES STANDARDIZATION AND ASCERTAINING
    • CRUCIAL CHECKING PARAMETERS
    • 2. REPRODUCIBILITY
    • 3. DIAGNOSTIC PARTICULARITY AND SENSITIVITY DETERMINATION
  • ASSAY CORROBORATION - PART 2
    • 1. ASSAY CONDUCT'S PERFORMANCE DETERMINATION
      • A) ANIMAL POPULATION'S REFERENCE
      • I) REFERENCE ANIMALS' NEGATIVITY
      • II) REFERENCE ANIMALS' POSITIVITY
      • III) OTHER ASSAYS' DETERMINATION OF STATUS OF REFERENCE ANIMALS
    • 2. ENTRY-LEVEL DETERMINATION
  • ASSAY CORROBORATION - PART 3
    • 1. STARTING ASSAY REPRODUCIBILITY
  • ASSAY CORROBORATION - PART 4
    • 1. CURRICULUM ACCOMPLISHMENT
    • 2. OBSERVING ASSAY FUNCTIONING'S VALIDITY
    • A) EXPLANATION OF ANALYSES' RESULTS - ISSUES UPSETTING ASSAY VALIDITY
    • B) MAINTAINING CORROBORATION CRITERIA
  • POLYMERASE CHAIN REACTION (PCR) - PRODUCT/TOOLS - GEOGRAPHY MARKET BRIEFING
    • NORTH AMERICA
    • EUROPE
    • ASIA-PACIFIC
    • LATIN AMERICA
    • REST OF WORLD

II. MARKET ANALYSIS

  • POLYMERASE CHAIN REACTION (PCR): PRODUCT/TOOLS - INDUSTRY SNAPSHOT

A. POLYMERASE CHAIN REACTION (PCR): PRODUCT/TOOLS - SEGMENTATION

  • POLYMERASE CHAIN REACTION (PCR) - GLOBAL
    • POLYMERASE CHAIN REACTION (PCR) - GEOGRAPHIC REGION
  • POLYMERASE CHAIN REACTION (PCR) - BY COUNTRY ANALYSIS
    • NORTH AMERICA
    • EUROPE
    • ASIA-PACIFIC
    • LATIN AMERICA
  • POLYMERASE CHAIN REACTION (PCR) - BY PRODUCT/TOOLS
  • POLYMERASECHAINREACTION (PCR) - PRODUCT/TOOLS - GEOGRAPHICREGION
  • PCR MACHINES
    • NORTH AMERICA
    • EUROPE
    • ASIA-PACIFIC
    • LATIN AMERICA
    • REST OF WORLD
  • PCR REAGENTS
    • NORTH AMERICA
    • EUROPE
    • ASIA-PACIFIC
    • LATIN AMERICA
    • REST OF WORLD
  • PCR CONSUMABLES
    • NORTH AMERICA
    • EUROPE
    • ASIA-PACIFIC
    • LATIN AMERICA
    • REST OF WORLD
  • OTHER PCR PRODUCT/TOOLS
    • NORTH AMERICA
    • EUROPE
    • ASIA-PACIFIC
    • LATIN AMERICA
    • REST OF WORLD

B. GROWTH RATE ANALYSIS

  • GLOBAL POLYMERASE CHAIN REACTION (PCR) - MARKET GROWTH RATES
  • POLYMERASE CHAIN REACTION (PCR) MARKET - PRODUCT/TOOLS
    • GLOBAL PCR PRODUCT/TOOLS - GROWTH RATES
  • PCR MACHINES
    • MARKET GROWTH RATES FOR PCR PRODUCT/TOOLS - PCR MACHINES
  • PCR REAGENTS
    • MARKET GROWTH RATES FOR PCR PRODUCT/TOOLS - PCR REAGENTS
  • PCR CONSUMABLES
    • MARKET GROWTH RATES FOR PCR PRODUCT/TOOLS - PCR CONSUMABLES

C. INVESTMENT FOCUS

III. INDUSTRY OVERVIEW

A. INDUSTRY ACTIVITIES

  • MERGERS/ACQUISITIONS/AGREEMENTS/PATENTS GRANTS/JOINT VENTURES/INNOVATIONS/PRODUCT LAUNCHES/ETC......
    • GENEWORKS CHAINS THE HUMAN MITOCHONDRIAL TRANSCRIPTOME
    • EPPENDORF GETS LICENSES TECHNOLOGY FOR THERMAL CYCLERS TO BULLDOG BIO
    • CALIPER LAUNCHES ZEPHYR NGS POST-PCR WORKSTATION
    • HKSH SELECTS GE HEALTHCARE'S PET/CT+MR FOR MANAGEMENT OF DISEASES
    • ABBOTT INTRODUCES ALK GENETIC TEST FOR NSCLC
    • QIAGEN ACQUIRES CELLESTIS
    • ABBOTT OBTAINS FDA APPROVAL FOR ALK GENE TEST
    • BIONEER RELEASES H1N1 VIRUS DIAGNOSTIC KIT
    • COMPLETE GENOMICS TO SEQUENCE DNA FOR NCI'S PEDIATRIC CANCER STUDY
    • ABBOTT GETS FDA CLEARANCE FOR VYSIS CLL FISH PROBE KIT
    • ABBOTT ANNOUNCES SUCCESSFUL TREATMENT OF THE FIRST PATIENT IN JAPAN WITH ABSORB™ BIORESORBABLE VASCULAR SCAFFOLD
    • QIAGEN AND PFIZER ANNOUNCE PARTNERSHIP
    • ABBOTT GETS FDA APPROVAL FOR RX HERCULINK ELITER RENAL STENT SYSTEM
    • ABBOTT INTRODUCES PLEX-ID™ VECTOR-BORNE TEST
    • BIOGEN IDEC AND ABBOTT ANNOUNCE SUCCESS OF SELECT TRIAL FOR RRMS
    • QIAGEN INAUGURATES TAIWAN SUBSIDIARY IN TAIPEI
    • QIAGEN COMPLETES SECOND U.S. SUBMISSION FOR THERASCREENR KRAS RGQ PCR KIT
    • ILLUMINA AND THE UNIVERSITY OF OXFORD COLLABORATE FOR PERSONALIZED MEDICINE
    • BD SIGNS AGREEMENT TO ACQUIRE CARMEL PHARMA
    • STARTING UP THE GENE THERAPY PROJECT IN CHINA
    • PROMEGAPOWERPLEXR 18D SYSTEM OBTAINS NDIS APPROVAL FOR OFFENDER DNA PROFILING
    • AFFYMETRIX STARTS SHIPMENT OF GENE PROFILING REAGENTS
    • LIFE TECHNOLOGIES INTRODUCES APPLIED BIOSYSTEMSVETMAXTM-GOLD SIV DETECTION KIT
    • BIOTAGE INTRODUCES MICROWAVE PEPTIDE SYNTHESIZER
    • RAISING THE BAR IN MICROWAVE SYNTHESIS BY BIOTAGE
    • COMPLETE GENOMICS INTRODUCES CANCER GRANT PROGRAM
    • PROMEGA INTRODUCES BIOLUMINESCENT HDAC ASSAYS
    • QIAGEN PREPARES PROPOSAL TO FULLY ACQUIRE IPSOGEN
    • ENZOBIOCHEM SIGNS AGREEMENT WITH INCELLDX AGREE TO MARKET HPV ONCOTECT™ TEST
    • EUROFINSMEDIGENOMIX'S NEW SERVICE FOR TESTING OF DNA CONTAMINATION
    • NEW SOFTWARE SPEEDS VALIDATION OF AUTOMATED LIQUID HANDLING PROCESSES
    • ABBOTT OBTAINS CE MARK FOR ITS REAL TIME PCR TEST FOR CMV
    • BD DIAGNOSTICS LAUNCHES BD MAX™ IN THE U.S.
    • LABSCO SET TO DISTRIBUTE CEPHEID'S GENEXPERT SYSTEMS
    • ABBOTT GETS FDA APPROVAL FOR MOLECULAR TEST FOR HEPATITIS C
    • AGILENT ANNOUNCES 2011 MANFRED DONIKE AWARD FOR EXCELLENCE IN SPORTS-DOPING DETECTION
    • ROCHE DIAGNOSTICS LAUNCHES ITS NEW BLOOD GAS ANALYZER
    • ROCHE DIAGNOSTICS LAUNCHES THE COBASR 8000 MODULAR ANALYZER
    • LIFE TECHNOLOGIES INTRODUCES 7500 FAST DX REAL-TIME PCR INSTRUMENT AND 3500 DX SERIES GENETIC ANALYZER IN JAPAN
    • AFFYMETRIX, FIRST IN THE INDUSTRY TO ACHIEVE FDA CLEARANCE FOR MICROARRAY-BASED GENE EXPRESSION REAGENTS
    • CALIPER ANNOUNCES RESEARCH COLLABORATION WITH CHI
    • AFFYMETRIX LAUNCHES SECOND GENERATION ONCOSCAN™ FFPE EXPRESS 2.0
    • AGILENT TECHNOLOGIES LAUNCHES AGILENT SURECYCLER 8800
    • LIFE TECHNOLOGIES FORTIFIES ITS DNA SEQUENCING PLATFORM
    • GENSCRIPT LAUNCHES GANPR TECH SERVICES GLOBALLY EXCLUDING JAPAN
    • ABBOTT RECEIVES CE MARK FOR NEW PCR-BASED HIV-1 TEST
    • QIAGEN RECEIVES SFDA APPROVAL FOR CAREHCV RT-PCR KIT V2
    • BD ACQUIRES ACCURI CYTOMETERS
    • AFFYMETRIX INTRODUCES SNP CORE REAGENT KIT FOR SNP ARRAY 6.0 CUSTOMERS
    • CALIPERS AND HISTORX JOINT VENTURE FOR TISSUE-BASED INTEGRATED SOLUTIONS FOR PROTEIN QUANTIFICATION OF BIOMARKERS
    • CYTOCELL DEVELOPS NEW FGFR1 FISH PROBE
    • AFFYMETRIX UNVEILS NEXT-GENERATION MICRORNA SOLUTION
    • INTEGENX AND CALIPER SIGN LICENSE AGREEMENT
    • CYTOCELL STARTS DISTRIBUTION IN BULGARIA
    • TAKARA BIO ESTABLISHES A SUBSIDIARY ...
    • GENE LOGIC INTRODUCES ASCENTA 4.0 WITH SUPERIOR FUNCTIONALITY
    • PROMEGA AND FUGENT LLC SIGN AGREEMENT FOR SUPPLY OF FUGENER 6
    • ABBOTT'S IBIS TECHNOLOGY TO IDENTIFY ORGANISM CAUSING PLAGUE IN AFGHANISTAN
    • ABBOTT PRESENTS THE PLEX-ID™ BIOTHREAT ASSAY
    • CYTOCELL LAUNCHES FIVE NEW T-CELL ALL FISH PROBES
    • PROMEGA LAUNCHES RELIAPREP™ BLOOD AND TISSUE GDNAMINIPREP SYSTEMS
    • LIFE TECHNOLOGIES LAUNCHES PCR DETECTION KIT FOR SALMONELLA ENTERITIDIS IN POULTRY EGGS
    • AFFYMETRIX LAUNCHES THE AXIOM(TM) GENOME-WIDE BOS 1 ARRAY FOR BOVINE GENOTYPING
    • ILLUMINA ACQUIRES EPICENTRE BIOTECHNOLOGIES
    • ILLUMINA AFFIRMS MISEQ(TM) PERSONAL SEQUENCING SYSTEM'S ADVANTAGES
    • ILLUMINA INTRODUCES NEXT GENERATION OF ISELECT(R) CUSTOM GENOTYPING PRODUCTS
    • BIOSPECTRUM HONORS OCIMUM BIOSOLUTIONS AS THE BEST BIOINFORMATICS COMPANY
    • CALIPER ACQUIRES CRI
    • CMB AND BIO RAD PARTNER TO DEVELOP DNA BARCODING INSTRUCTIONAL ACTIVITIES
    • SPARTAN RX CYP2C19 RECEIVES CE MARKING
    • OCIMUM CLOSES $8 MILLION TO FUEL FUTURE GROWTH
    • CALIPER SIGNS AGREEMENT TO ACQUIRE CRI
    • AGILENT AND UC DAVIS COLLABORATE FOR FOOD SAFETY RESEARCH
    • LIFE TECHNOLOGIES LAUNCHES APPLIED BIOSYSTEMSVETMAX-GOLD BVDV DETECTION KIT
    • ONLINE QUOTATION SYSTEM FOR POLYCLONAL ANTIBODY SERVICE BY GENSCRIPT
    • IMMUNOLOGIX TEAMS WITH GENSCRIPT
    • ILLUMINA INTRODUCES TRUSEQ(TM) SAMPLE PREP AND EXOME ENRICHMENT KITS
    • ADDITION OF GENE EDITING TECHNOLOGY
    • AXIOM ANALYTICAL'S ACCURATE TEMPERATURE CONTROL WITH FIBER-OPTIC
    • QIAGEN LAUNCHED STANDARDIZED SOLUTIONS FOR MOLECULAR ANALYSIS OF FFPE SAMPLES
    • TAKARA BIO GETS ANTI-CANCER DRUG
    • FDA CONSENTS ROCHE'S REAL-TIME PCR COBAS TAQMAN HCV TEST, V2.0
    • SPRYCEL OBTAINS CHMP POSITIVE OPINION FOR NEWLY DIAGNOSED PHILADELPHIA CHROMOSOME POSITIVE CML IN CHRONIC PHASE
    • NEW ENGLAND BIOLABS, INC. LAUNCHES PCR-BASED ASSAY TO IDENTIFY AND QUANTITATE 5-HMC IN EPIGENOME.
    • LEADING UK HOSPITAL DEMONSTRATES DETECT-READY™ MRSA OF MOLECULAR DETECTION INC.
    • EXIQON CUSTOM DESIGNS IN SITU HYBRIDIZATION
    • CHINA MEDICAL TECHNOLOGIES, INC.- A PIONEER RECEIVED APPROVAL FOR FIRST EVER SELF-DEVELOPED EGFR PCR ASSAY FOR LUNG CANCER TARGETED DRUGS
    • CORNING COMPLETES ACQUISITION OF PLASLAB S.A.S.
    • BOEHRINGERINGELHEIM AND EUROFINSMEDIGENOMIX GMBH SIGN SERVICE AGREEMENT FOR DNA BANKING AND PHARMACOGENETICS / PHARMACOGENOMICS
    • BIOFORTUNA LTD. RELEASES WORLD'S FIRST FREEZE-DRIED SOLUTION
    • ANASPEC, INC. LAUNCHES MESA BLUE QPCR MIXES FOR SYBR(R) ASSAY
    • OMEROS CORPORATION - SPOTTED CHEMOTHERAPEUTIC BUSTLE
    • VIRACOR-IBT LABORATORIES INTRODUCES ASPERGILLUS PCR PANEL AND ADVANCES FUNGAL TESTING SERVICES
    • SEEGENE, INC. READ PCR HAS INVENTED THE TESTS FOR BOTH TB AND SEXUALLY TRANSMITTED DISEASE
    • QIAGEN'S NEW AUTOMATED MODULAR TESTING PLATFORM FOR MOLECULAR DIAGNOSTICS
    • AGILENT AUTOMATION SOLUTIONS REVELS THE WAYS TO LEAD SUCCESSFUL QPCR AUTOMATION
    • EPPENDROF'S DIVISIBLE PCR PLATES
    • QUANTALIFE TRIUMPHS WITH $820K FROM NIH TO DEVELOP MRSA TEST FOR DIGITAL PCR PLATFORM
    • FOURTH ANNUAL QPCR SYMPOSIUM IN USA TO BE HOSTED BY INTELLIGENT ENTERPRISE SOLUTIONS, INC.
    • TRANSGENOMIC, INC. (TBIO) DEVELOPS NEW ASSAYS TO DETECT EGFR MUTATIONS
    • PROMEGA ADVANCES THROUGH NEW GOTAQR 2-STEP RT-QPCR SYSTEM
    • WAFERGEN BIOSYSTEMS ENTERS INTO A DISTRIBUTION AGREEMENT OF SMARTCHIP REAL-TIME PCR
    • ASURAGEN REVELS THE USES OF PCR-ONLY TECHNOLOGIES WITH ITS COLLABORATORS
    • BIOSERVE'S COST EFFECTIVE PCR-BASED GMO SCREENING TESTS
    • ROCHE AND EXIQON - JOINT VENTURE FOR THEIR RT PCR ASSAY SYSTEMS
    • EMIR DUZIC TO LEAD GPCR ASSAY SERVICES FOR CHANTEST CORPORATION
    • TREVENA, INC. SAFE AND SOUND COMPLETE PHASE 2 STUDY OF TRV120027 FOR ACUTE HEART FAILURE
    • ROCHE OBTAINS CO-EXCLUSIVE LICENSE FROM QIAGEN INC.
    • MILLIPORE CORPORATION ENABLE NEW INSIGHTS INTO GPCR ACTIVITY
    • ABBOTT RECEIVES FDA APPROVAL FOR MOLECULAR DIAGNOSTIC TEST FOR GONORRHEA AND CHLAMYDIA DETECTION
    • OMEROS UNLOCKS ORPHAN GPCRS
    • KYOTO UNIVERSITY TO USE SMARTCHIP REAL-TIME PCR BY WAFERGEN BIOSYSTEMS TO DIFFERENTIATE BIOMARKERS
    • ENDOGENOUS GPCRS USING THE XCELLIGENCE SYSTEM FOR FUNCTIONAL CELL PROFILING
    • EXIQON AND MULTID ENTERS INTO AN AGREEMENT TO TAILOR MICRORNA QPCR ANALYSIS SOLUTION
    • ERAGEN BIOSCIENCES INC. CLEARS FDA FOR ITS FIRST HERPES SIMPLEX VIRUS PCR TEST
    • WAFERGEN BIOSYSTEMS LAUNCHES BREAKTHROUGH SMARTCHIP REAL-TIME PCR SYSTEM
    • AFFYMETRIX LAUNCHES AFFYMETRIX(R) MIP COPY NUMBER SERVICE FOR CHALLENGING FFPE SAMPLES
    • ROCHE'S LIGHTCYCLERR 1536 INSTRUMENT WILL BE USED BY GHENT UNIVERSITY IN THE FIELD OF HT PCR FOR CANCER RESEARCH
    • THERMO FISHER SCIENTIFIC INC., HELPS RESEARCHERS FOR PCR PLASTICS
    • FDA GIVES APPROVAL TO NEW ROCHE DUAL-PCR TARGET HIV-1 TEST
    • THE U.S. PATENT AND TRADEMARK OFFICE ISSUES EXCLUSIVE PATENT TO IDAHO TECHNOLOGY
    • ABBOTT AND GSK COLLABORATE FOR MOLECULAR DIAGNOSTIC TEST FOR MAGE-A3 ASCI ELIGIBILITY
    • AFFYMETRIX RELEASES GENEATLAS™ PERSONAL MICROARRAY SYSTEM FOR WHOLE-GENOME ANALYSIS
    • LIFE TECHNOLOGIES ADDS IVD MARK FOR REAL-TIME PCR INSTRUMENT
    • CONVENTIONAL PCR AND REAL-TIME PCR TECHNIQUES BY SEEGENE, INC. WITH NEW POTENTIAL PLATFORM FOR NEW MOLECULAR DIAGNOSTIC TESTS
    • QUANTALIFE LAUNCHED DROPLET DIGITAL(TM) PCR SYSTEM
    • ABBOTT RECEIVES CE MARK FOR NEW GENE-BASED TEST FOR COLORECTAL CANCER
    • THE SCIENTIST' NAMES ABBOTT'S IBIS TECHNOLOGY ONE OF THE TOP INNOVATIONS FOR 2009
    • A SMARTCHIP™ REAL-TIME PCR SYSTEM LAUNCHED BY WAFERGEN BIOSYSTEMS AS A HUMAN MICRORNA PANEL FOR GENE-EXPRESSION PROFILING OF 885 MICRORNA.
    • DXNA'S GENESTAT™ - DETECTION OF INFLUENZA H1N1 VIRUS GETS AUTHORIZED BY FDA.
    • THE INVENTION OF MORE ACCURATE PCR PRODUCTS BY THERMO FISHER SCIENTIFIC INC.
    • WAFERGEN BIOSYSTEMS INTRODUCES A NEW GENE-EXPRESSION PROFILING SERVICE USING THE SMARTCHIP™ REAL-TIME PCR SYSTEM.
    • INNOVATION OF AUTOMATED PCR DX FOR HLA AND COELIAC DISEASE.
    • CELLAURA TECHNOLOGIES LTD TIES UP WITH CISBIO BIOASSAYS TO DEVELOP REAGENTS FOR TAG-LITE™ GPCR TECHNOLOGY.
    • EXIQON A/S LAUNCHES A NEW MICRORNA QPCR EXPRESSION PLATFORM.
    • TRANSGENOMIC, INC. SIGNS AN AGREEMENT WITH DANA-FARBER CANCER INSTITUTE FOR COLD-PCR TECHNOLOGY.
    • A BRAND-NEW WORKSTATION FOR PCR BY HOEFER, INC.
    • A NEW GENOMIC ANALYSIS TOOLS LAUNCHED
    • QIAGEN ADOPTS HRM TECHNOLOGY IN GENOTYPING
    • DXS LTD MERGES WITH QIAGEN
    • ROCHE AND IDAHO TECHNOLOGY OFFERS PCR LICENSE TO QIAGEN
    • ABBOTT AND PFIZER PARTNER FOR COMPANION DIAGNOSTIC TEST TO SCREEN NSCLC
    • CELEBRATIONS AT THERMO FISHER SCIENTIFIC (TMO)
    • BIOSTATUS LTD.'S DRAQ5 - A BEQUEST TO GENETIC STUDY
    • ABBOTT COLLABORATES WITH GSK FOR MOLECULAR DIAGNOSTIC TEST FOR MAGE-A3 ANTIGEN
    • NEW PCR ASSAYS TO QUANTIFY PROTEIN IN HUMAN CELLS
    • RT-PCR TECHNOLOGY TO PROVIDE DIAGNOSTIC TESTS FOR SWINE H1N1 INFLUENZA
    • LAB901'S NEW PRODUCT
    • NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES OFFERS GRANT TO CEPHEID
    • ELITECH MERGES WITHNANOGEN
    • ABBOTT REALTIME VIRAL LOAD TEST RECOMMENDED FOR NIH-SPONSORED CLINICAL TRIALS
    • ROCHE DIAGNOSTICS CORPORATION MAKES TUBERCULOSIS TESTING EASIER
    • NEW REAL-TIME PCR SOLUTION LAUNCHED BY APPLIED BIOSYSTEMS
    • LUCRATIVE FAST PCR TEST-KITS FOR HIV/AIDS TESTING EMERGE WITH A COLLABORATION OF SPARTAN BIOSCIENCE AND COOPERATIVE DIAGNOSTICS.
    • BIOXPR SA ANNOUNCES NEW PROPOSALS AND SERVICES IN GENETIC ANALYSIS
    • SPARTAN BIOSCIENCE SPREADS ITS ROOTS IN DNA MARKET
    • ENZO BIOCHEM TAKES OVER ASSAY DESIGNS INC.
    • HIGH RANGE THROUGHPUT FOR DIGITAL PCR BY FLUIDIGM CORPORATION'S NOVEL DIGITAL ARRAY
    • NANOGEN EXPANDS ITS PARTNERSHIP
    • NOVEL GPCR ASSAY STRATEGY GRANTED PATENT
    • OPENARRAYR DLP REAL-TIME QPCR PLATFORM- A NEW INTRODUCTION BY BIOTROVE
    • NEW LAUNCHES OF BIOTROVE, INC.
    • ABBOTT INTRODUCES REALTIME HIGH RISK HPV ASSAY IN EUROPE
    • FLUIDIGM IN EARLY DETECTION OF LEUKEMIA
    • QIAGEN AND APPLIED BIOSYSTEMS SETTLES A SINGLE PATENT FOR REAL-TIME THERMAL CYCLER
    • GLOBAL LICENSE AGREEMENT BETWEEN EVOGEN AND LGC ON NOVEL HYBEACONS(R)
    • ROLE OF PCR AND FCR IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
    • FINDINGS OF US ONCOLOGY, INC. (USON) IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA
    • EPPENDORF TO CHECK EVAPORATION IN PCR TESTING.
    • ASURAGEN, INC. INSTIGATES A MULTIPLEX QRT-PCR ASSAY.
    • PANOMICS TAKE OVER BY AFFYMETRIX
    • SUNSHINE BIO INVESTMENTS WORLD FUNDS MULTI-BILLION DOLLAR NORTH AMERICAN MARKETS
    • LICENSING AGREEMENT BETWEEN MP BIOMEDICALS, INC. AND A*STAR
    • UPGRADED VERSION OF ENIGMA FIELD LABORATORY (FL) INVENTED BY ENIGMA DIAGNOSTICS.
    • INTEGRATED DNA TECHNOLOGIES' FIRST ASSAY PRODUCT.
    • A NEW APPROACH TO REAL-TIME PCR ANALYSIS
    • TAQMANR SAMPLE-TO-SNP™ KIT-A GIFT TO LIFE SCIENCES INDUSTRY.
    • COMPLETE GENOMICS DECLARED AS WORLD'S FIRST LARGE-SCALE HUMAN GENOME SEQUENCING COMPANY
    • INTEGRATED DNA TECHNOLOGIES ACQUIRES LICENSE FOR REAL-TIME PCR PROBE LICENSING PROGRAM
    • SEQUENOM INC. AND GENOMIC NANOSYSTEMS HAS A LICENSE AGREEMENT.
    • A SERVICE PROVIDER PROGRAM LAUNCHED BY APPLIED BIOSYSTEMS, INC.
    • FORENSIC DNA ANALYSIS - EPSYSTEM GUIDE NO.12.
    • METAHELIX LIFE SCIENCES TO TEAM UP WITH SIGMA-ALDRICH
    • QIAGEN TAKES OVER CORBETT LIFE SCIENCE
    • PALM-SIZE PORTABLE PCR DEVICE BY AHRAM BIOSYSTEMS.
    • REAL-TIME PCR TECHNOLOGY FOR FORENSICS DNA ANALYSIS
    • REAL-TIME PCR AN ADDITION TO BIO-RAD'S COLLECTION.
    • NEW SOLUTIONS FOR LEAD OPTIMIZATION AND CELL-BASED GPCR PROFILING.
    • BIOTECON DIAGNOSTICS ENTERS INTO AGREEMENT WITH APPLERA CORPORATION
    • TRIMGEN CORPORATION AND SPARTAN BIOSCIENCE OFFERS REAL-TIME PCR SOLUTIONS
    • INVITROGEN AND GENISPHERE COME TOGETHER FOR ADVANCE EPIGENETIC RESEARCH
    • AFFYMETRIX ACQUIRES USB CORPORATION
    • WAFERGEN LAUNCHES SUBSIDIARY AT KEDAH, MALAYSIA
    • ROSETTA GENOMICS LICENSED USER OF PCR TECHNOLOGY

B. MARKET TRENDS

  • SPARTAN BIOSCIENCE DX-12 ™ DNA ANALYZER - A BOON TO BIOTECHNOLOGY
  • REDDYMIX - A BUFFER FOR PCR REAGENTS
  • NEXT GENERATION PCR APPROVES EVOLUTION POLYMERASES
  • QUICKPROBE(TM) QPCR- A BONUS TO LIFE SCIENCES COMPANIES
  • MASTER CLEAR CAP STRIPSR - AN ADDITION TO PCR CONSUMABLES
  • DIGITAL PCR TECHNOLOGY BY FLUIDIGM
  • GREENECHIP TECHNOLOGY- UNPREJUDICED PATHOGEN DISCOVERY
  • INCREASING DEMAND FOR QRT-PCR PRODUCTS
  • QIAGEN'S NEW SOLUTION TO ACCELERATE PCR
  • OPTO TECHNOLOGY'S NEW INVENTION - OTHP-0050
  • TIE UP BETWEEN FISHER BIOSCIENCES AND APPLIED BIOSYSTEMS
  • FISHER BIOSCIENCES AND DYOMICS MERGE FOR BETTERMENT
  • PCR MACHINES - IMPACT ON LIFE SCIENCES EQUIPMENT.

C. INDUSTRY LEADERS

  • ABBOTT LABORATORIES (USA)
  • AGILENT TECHNOLOGIES INC (USA)
  • APPLIED BIOSYSTEMS INC (USA)
  • BIONEER INC (USA)
  • COMPLETE GENOMICS, INC. (USA)
  • EPICENTRER BIOTECHNOLOGIES (USA)
  • GENISPHERE INC. (USA)
  • MAXIM BIOTECH, INC (USA)
  • OCIMUM BIOSOLUTIONS LTD.
  • QIAGEN INC (USA)
  • SACACE BIOTECHNOLOGIES S.R.L. (ITALY)
  • TAKARA BIO, INC.
  • THERMO FISHER SCIENTIFIC, INC.
  • LIGHTUP TECHNOLOGIES AB (SWEDEN)
  • HY LABORATORIES LTD. (ISRAEL)

D. POLYMERASE CHAIN REACTION (PCR) - A LOOK A HEAD..!!

E. KEY COMPANY PROFILES

  • NORTH AMERICA
  • EUROPE
  • ASIA-PACIFIC
  • REST OF WORLD

IV. INDUSTRY COMPANY DATABASE

V. APPENDIX

  • A. RESEARCH FOCUS
  • B. ABOUT AXIS RESEARCH MIND
  • C. DISCLAIMER
  • D. FEEDBACK

LIST OF TABLES/CHARTS

  • I. REPORT FOCUS
    • 1. PCR THERMOCYCLER BRANDS BY KEY PLAYERS
    • 2. WORLDWIDE KEY PLAYERS MARKET SHARES OF Q-PCR REAGENTS - (2009-2010)
  • POLYMERASE CHAIN REACTION (PCR): PRODUCT/TOOLS - GEOGRAPHY MARKET BRIEFING
    • 3. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER FOR NORTH AMERICA - (2009-2015, IN USD$ MILLION)
    • 4. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER - % OF NORTH AMERICAN MARKET VALUE - (2010 - 2015)
    • 5. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER FOR EUROPE - (2009-2015, IN USD$ MILLION)
    • 6. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER - % OF EUROPEAN MARKET VALUE - (2010 - 2015)
    • 7. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER FOR ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
    • 8. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER - % OF ASIA-PACIFIC MARKET VALUE - (2010 - 2015)
    • 9. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER FOR LATIN AMERICA - (2009-2015, IN USD$ MILLION)
    • 10. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER - % OF LATIN AMERICAN MARKET VALUE - (2010 - 2015)
    • 11. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER FOR REST OF WORLD - (2009-2015, IN USD$ MILLION)
    • 12. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER - % OF REST OF WORLD MARKET VALUE - (2010 - 2015)
  • II. MARKET ANALYSIS
  • A. POLYMERASE CHAIN REACTION (PCR): PRODUCT/TOOLS - SEGMENTATION
    • 13. GLOBAL POLYMERASE CHAIN REACTION (PCR) - SEGMENTATION BY PRODUCT/TOOLS
  • B. POLYMERASE CHAIN REACTION (PCR) - GLOBAL
    • 14. POLYMERASE CHAIN REACTION (PCR) MARKET - CURRENT TRENDS, ESTIMATES & FORECASTS- (2009-2015, IN USD$ MILLION)
    • 15. PCR MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
    • 16. PCR MARKET - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2010 - 2015)
  • B1. POLYMERASE CHAIN REACTION (PCR) - BY COUNTRY ANALYSIS
    • 17. PCR MARKET - USA AND CANADA - (2009-2015, IN USD$ MILLION)
    • 18. PCR MARKET - % OF USA AND CANADA MARKET VALUE - (2010 - 2015)
    • 19. PCR MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
    • 20. PCR MARKET - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN AND REST OF EUROPE MARKET VALUE - (2010 - 2015)
    • 21. PCR MARKET - JAPAN, CHINA, INDIA, S&N KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
    • 22. PCR MARKET - % OF JAPAN, CHINA, INDIA, S&N KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2010 - 2015)
    • 23. PCR MARKET - BRAZIL, COLUMBIA, ARGENTINA AND REST OF LATIN AMERICA - (2009-2015, IN USD$ MILLION)
    • 24. PCR MARKET- % OF BRAZIL, COLUMBIA, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2010 - 2015)
  • I. POLYMERASE CHAIN REACTION (PCR) - BY PRODUCT/TOOLS
    • 25. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER FOR GLOBAL CURRENT TRENDS, ESTIMATES &FORECASTS - (2009-2015, IN USD$ MILLION)
    • 26. PCR PRODUCT/TOOLS MARKET - PCR MACHINES, PCR REAGENTS, PCR CONSUMABLES AND OTHER - % OF GLOBAL MARKET VALUE - (2010 - 2015)
  • POLYMERASE CHAIN REACTION (PCR) - PRODUCT/TOOLS - GEOGRAPHICREGION
  • I.A. PCR MACHINES
    • 27. PCR MACHINES MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
    • 28. PCR MACHINES MARKET - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2010 - 2015)
    • 29. PCR MACHINES MARKET - USA AND CANADA - (2009-2015, IN USD$ MILLION)
    • 30. PCR MACHINES MARKET - % OF USA AND CANADA MARKET VALUE - (2010 - 2015)
    • 31. PCR MACHINES MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
    • 32. PCR MACHINES MARKET - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN AND REST OF EUROPE MARKETVALUE - (2010 - 2015)
    • 33. PCR MACHINES MARKET - JAPAN, CHINA, INDIA, S&N KOREA AND REST OF ASIA-PACIFIC - (2009-2015, INUSD$ MILLION)
    • 34. PCR MACHINES MARKET - % OF JAPAN, CHINA, INDIA, S&N KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2010 - 2015)
    • 35. PCR MACHINES MARKET - BRAZIL, COLUMBIA, ARGENTINA AND REST OF LATIN AMERICA - (2009-2015, INUSD$ MILLION)
    • 36. PCR MACHINES MARKET - % OF BRAZIL, COLUMBIA, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2010 - 2015)
    • 37. PCR MACHINES MARKET - REST OF WORLD - (2009-2015, INUSD$ MILLION)
  • I.B. PCR REAGENTS
    • 38. PCR REAGENTS MARKET - GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
    • 39. PCR REAGENTS MARKET - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2010 - 2015)
    • 40. PCR REAGENTS MARKET - USA AND CANADA - (2009-2015, INUSD$ MILLION)
    • 41. PCR REAGENTS MARKET - % OF USA AND CANADA MARKET VALUE - (2010 - 2015)
    • 42. PCR REAGENTS MARKET- GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN AND REST OF EUROPE - (2009-2015, INUSD$ MILLION)
    • 43. PCR REAGENTS MARKET - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN AND REST OF EUROPE MARKET VALUE - (2010 - 2015)
    • 44. PCR REAGENTS MARKET - JAPAN, CHINA, INDIA, S&N KOREA AND REST OF ASIA-PACIFIC - (2009-2015, INUSD$ MILLION)
    • 45. PCR REAGENTS MARKET - % OF JAPAN, CHINA, INDIA, S&N KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2010 - 2015)
    • 46. PCR REAGENTS MARKET -BRAZIL, COLUMBIA, ARGENTINA AND REST OF LATIN AMERICA -(2009-2015, INUSD$ MILLION)
    • 47. PCR REAGENTS MARKET - % OF BRAZIL, COLUMBIA, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2010 - 2015)
    • 48. PCR REAGENTS MARKET - REST OF WORLD - (2009-2015, INUSD$ MILLION)
  • I.C. PCR CONSUMABLES
    • 49. PCR CONSUMABLES MARKET -GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
    • 50. PCR CONSUMABLES MARKET - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2010 - 2015)
    • 51. PCR CONSUMABLES MARKET - USA AND CANADA - (2009-2015, IN USD$ MILLION)
    • 52. PCR CONSUMABLES MARKET - % OF USA AND CANADA MARKET VALUE - (2010 - 2015)
    • 53. PCR CONSUMABLES MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
    • 54. PCR CONSUMABLES MARKET - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN AND REST OF EUROPE MARKET VALUE - (2010 - 2015)
    • 55. PCR CONSUMABLES MARKET - JAPAN, CHINA, INDIA, S&N KOREA ANDREST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
    • 56. PCR CONSUMABLES MARKET - % OF JAPAN, CHINA, INDIA, S&N KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2010 - 2015)
    • 57. PCR CONSUMABLES MARKET -BRAZIL, COLUMBIA, ARGENTINA AND REST OF LATIN AMERICA - (2009-2015, IN USD$ MILLION)
    • 58. PCR CONSUMABLES MARKET - % OF BRAZIL, COLUMBIA, ARGENTINA AND REST OFLATIN AMERICA MARKET VALUE - (2010 - 2015)
    • 59. PCR CONSUMABLES MARKET - REST OF WORLD - (2009-2015, IN USD$ MILLION)
  • I.D. OTHER PCR PRODUCT/TOOLS
    • 60. OTHER PCR PRODUCT/TOOLS MARKET -GEOGRAPHIC REGION CURRENT TRENDS, ESTIMATES & FORECASTS FOR NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD - (2009-2015, IN USD$ MILLION)
    • 61. OTHER PCR PRODUCT/TOOLS MARKET - % OF NORTH AMERICA, EUROPE, ASIA-PACIFIC, LATIN AMERICA AND REST OF WORLD MARKET VALUE - (2010 - 2015)
    • 62. OTHER PCR PRODUCT/TOOLS MARKET - USA AND CANADA - (2009-2015, IN USD$ MILLION)
    • 63. OTHER PCR PRODUCT/TOOLS MARKET - % OF USA AND CANADA MARKET VALUE - (2010 - 2015)
    • 64. OTHER PCR PRODUCT/TOOLS MARKET - GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN AND REST OF EUROPE - (2009-2015, IN USD$ MILLION)
    • 65. OTHER PCR PRODUCT/TOOLS MARKET - % OF GERMANY, FRANCE, UNITED KINGDOM, ITALY, SPAIN AND REST OF EUROPE MARKET VALUE - (2010 - 2015)
    • 66. OTHER PCR PRODUCT/TOOLS MARKET - JAPAN, CHINA, INDIA, S&N KOREA AND REST OF ASIA-PACIFIC - (2009-2015, IN USD$ MILLION)
    • 67. OTHER PCR PRODUCT/TOOLS MARKET - % OF JAPAN, CHINA, INDIA, S&N KOREA AND REST OF ASIA-PACIFIC MARKET VALUE - (2010 - 2015)
    • 68. OTHER PCR PRODUCT/TOOLS MARKET -BRAZIL, COLUMBIA, ARGENTINA AND REST OF LATIN AMERICA - (2009-2015, IN USD$ MILLION)
    • 69. OTHER PCR PRODUCT/TOOLS MARKET - % OF BRAZIL, COLUMBIA, ARGENTINA AND REST OF LATIN AMERICA MARKET VALUE - (2010 - 2015)
    • 70. OTHER PCR PRODUCT/TOOLS MARKET - REST OF WORLD - (2009-2015, IN USD$ MILLION)
  • C. GROWTH RATE ANALYSIS
  • GLOBAL POLYMERASE CHAIN REACTION (PCR) - MARKET GROWTH RATES
    • 71. PCR MARKET - GEOGRAPHIC REGION - % GROWTH RATE FORECASTS - (2009-2015)
  • C.1. POLYMERASE CHAIN REACTION (PCR) MARKET - PRODUCT/TOOLS
  • GLOBAL PCR PRODUCT/TOOLS - GROWTH RATES
    • 72. PCR PRODUCT/TOOLS - % GROWTH RATE FORECASTS FOR PCR MACHINES, PCR REAGENTS AND PCR CONSUMABLES - (2009-2015)
    • 73. PCR MACHINES - GEOGRAPHIC REGION - % GROWTH RATE FORECASTS - (2009-2015)
    • 74. PCR REAGENTS - GEOGRAPHIC REGION - % GROWTH RATE FORECASTS - (2009-2015)
    • 75. PCR CONSUMABLES - GEOGRAPHIC REGION - % GROWTH RATE FORECASTS - (2009-2015)
  • III. INDUSTRY OVERVIEW
    • 76. LIST OF KEY PLAYERS WORLDWIDE FOR POLYMERASE CHAIN REACTION (PCR)
    • 77. ABBOTT LABORATORIES: WORLDWIDE NET SALES AND R&D EXPENSES FOR THE YEARS - (2010-2009-2008 - USD BILLION)
    • 78. ABBOTT LABORATORIES: WORLDWIDE BREAKDOWN OF NET SALES BY COUNTRY - (2010-2009-2008 - USD MILLION)
    • 79. ABBOTT LABORATORIES: COMPONENTS OF SALES GROWTH BY REPORTABLE SEGMENT - (2010-2009-2008 - USD MILLION)
    • 80. ABBOTT LABORATORIES: NET SALES WORLDWIDE AND NON-US - (2006-2010, IN USD MILLION)
    • 81. AFFYMETRIX, INC.: NET SALES BY GEOGRAPHIC REGION - (2010-2009-2008, IN USD THOUSAND)
    • 82. LIFE TECHNOLOGIES CORPORATION: BREAKDOWN OF NET REVENUES BY INDUSTRY SEGMENT - (2008-2009-2010, IN USD MILLION)
    • 83. LIFE TECHNOLOGIES CORPORATION: BREAKDOWN OF NET REVENUES BY GEOGRAPHY - (2008-2009-2010, IN USD MILLION)
    • 84. BD BIOSCIENCES: BREAKDOWN OF NET SALES BY INDUSTRY SEGMENTS - (2010-2009-2008, IN USD MILLION)
    • 85. BD BIOSCIENCES: COMPANY REVENUES-GENERATING INTO THE FOLLOWING GEOGRAPHIC AREAS - (2010-2009-2008, IN USD MILLION)
    • 86. BECKMAN COULTER: BREAKDOWN OF TOTAL REVENUE BY SEGMENT/CATEGORY (2009 AND 2008, IN USD MILLION)
    • 87. BECKMAN COULTER: BREAKDOWN OF TOTAL REVENUE BY GEOGRAPHIC REGION - (2009 AND 2008, IN USD MILLION)
    • 88. BECKMAN COULTER: INSTRUMENT SALES - (2009-2008-2007-2006-2005, IN USD MILLION)
    • 89. BIO-RAD LABORATORIES, INC.: REVENUES GENERATING FOR THE INDUSTRY SEGMENTS - (2010-2009-2008, IN USD MILLION)
    • 90. BIO-RAD LABORATORIES, INC.: NET SALES BY GEOGRAPHIC AREA - (2010-2009-2008 IN USD MILLION)
    • 91. CALIPER LIFE SCIENCES, INC.: BREAKDOWN OF REVENUES BY SEGMENT - (2010 AND 2009, IN USD THOUSAND)
    • 92. CALIPER LIFE SCIENCES, INC.: RESEARCH AND DEVELOPMENT EXPENSES - (2010-2009-2008, IN USD IN MILLION)
    • 93. CALIPER LIFE SCIENCES, INC.: BREAKDOWN OF REVENUES BY GEOGRAPHY - (2010-2009-2008, IN USD THOUSAND)
    • 94. CEPHEID: PRODUCT SALES IN THE CLINICAL, INDUSTRIAL, BIOTHREAT AND PARTNER MARKETS - (2010-2009-2008, IN USD THOUSAND)
    • 95. CEPHEID: BREAKDOWN OF PRODUCT SALES BY GEOGRAPHIC REGIONS - (2010-2009-2008, IN USD THOUSAND)
    • 96. COMPLETE GENOMICS, INC.: NET SALES AND RESEARCH AND DEVELOPMENT EXPENSES - (2009 AND 2010, IN USD THOUSAND)
    • 97. ENZO BIOCHEM: BREAKDOWN OF SALES BY GEOGRAPHIC REGION - (2010-2009-2008, IN USD THOUSAND)
    • 98. GE HEALTHCARE: CONSOLIDATED TOTAL NET REVENUES AND PROFITS BY INDUSTRY SEGMENT (2008-2009-2010, IN USD MILLION) & RESEARCH AND DEVELOPMENT EXPENSES (2008-2009-2010, IN USD BILLION)
    • 99. GE HEALTHCARE: GEOGRAPHY BREAKDOWN OF NET REVENUES - (2010-2009-2008, IN USD BILLION)
    • 100. ILLUMINA: NET REVENUES BY CATEGORY AND RESEARCH AND DEVELOPMENT EXPENSES - (2010-2009-2008, IN USD THOUSAND)
    • 101. ILLUMINA: BREAKDOWN OF NET REVENUES BY GEOGRAPHY - (2010-2009-2008, IN USD THOUSAND)
    • 102. QIAGEN, INC.: BREAKDOWN OF NET REVENUE BY GEOGRAPHY - (2010-2009-2008, IN USD THOUSAND)
    • 103. QIAGEN, INC.: BREAKDOWN OF LEADING SEGMENTS AND TYPES - 2010 %AGE GROWTH RATES
    • 104. ROCHE DIAGNOSTICS: PHARMACEUTICALS DIVISION MAJOR REGULATORY APPROVALS IN VARIOUS COUNTRIES FOR THE FIRST HALF OF 2011
    • 105. ROCHE DIAGNOSTICS: PHARMACEUTICALS DIVISION MAJOR REGULATORY FILINGS IN VARIOUS COUNTRIES FOR THE FIRST HALF OF 2011
    • 106. ROCHE DIAGNOSTICS: NET SALES BY INDUSTRY SEGMENTS AND RESEARCH AND DEVELOPMENT EXPENSES - (2010 AND 2011, IN MILLION CHF)
    • 107. ROCHE DIAGNOSTICS: PHARMACEUTICALS DIVISION - NET SALES BY THERAPEUTIC AREA - (2011, IN MILLION CHF)
    • 108. ROCHE DIAGNOSTICS: PHARMACEUTICALS DIVISION - NET SALES BY GEOGRAPHIC REGION - (2011, IN MILLION CHF)
    • 109. ROCHE DIAGNOSTICS: DIAGNOSTICS DIVISION - NET SALES BY BUSINESS AREA - (2011, IN MILLION CHF)
    • 110. ROCHE DIAGNOSTICS: DIAGNOSTICS DIVISION - NET SALES BY GEOGRAPHIC REGION - (2011, IN MILLION CHF)
    • 111. THERMO FISHER SCIENTIFIC, INC.: BREAKDOWN OF TOTAL REVENUE BY SEGMENT & RESEARCH AND DEVELOPMENT EXPENSES - (2010-2009-2008, IN USD MILLION)
    • 112. THERMO FISHER SCIENTIFIC, INC.: BREAKDOWN OF TOTAL REVENUE BY GEOGRAPHIC REGION - (2010-2009-2008, IN USD MILLION)
    • 113. THERMO FISHER SCIENTIFIC, INC.: BREAKDOWN OF TOTAL REVENUE BY END-USE MARKET - (2010, IN USD MILLION)
    • 114. THERMO FISHER SCIENTIFIC, INC.: BREAKDOWN OF TOTAL REVENUE BY PRODUCT CATEGORY - (2010, IN USD MILLION)
    • 115. EPPENDORF AG: BREAKDOWN OF SALES BY GEOGRAPHIC REGION - (2010-2009-2008, IN GBP MILLION)
    • 116. TAKARA BIO, INC.: BREAKDOWN OF NET SALES BY BUSINESS SEGMENT AND RESEARCH &DEVELOPMENT EXPENSES - (2008-2009-2010, IN MILLION OF YEN)
    • 117. TAKARA BIO, INC.: BREAKDOWN OF NET SALES BY GEOGRAPHIC AREA - (2010, IN MILLION OF YEN)

LIST OF KEY COMPANIES

  • NORTH AMERICA
    • ABBOTT LABORATORIES
    • AFFYMETRIX, INC.
    • AGILENT TECHNOLOGIES, INC.
    • LIFE TECHNOLOGIES CORPORATION
    • BD BIOSCIENCES
    • BECKMAN COULTER, INC.
    • BIONEER, INC.
    • BIO-RAD LABORATORIES, INC.
    • BIOTROVE
    • CALIPER LIFE SCIENCES, INC.
    • CEPHEID
    • COMBIMATRIX CORPORATION
    • COMMONWEALTH BIOTECHNOLOGIES, INC.
    • COMPLETE GENOMICS, INC.
    • ENZO BIOCHEM
    • EPICENTRER BIOTECHNOLOGIES
    • GE HEALTHCARE (LIFE SCIENCES)
    • GENISPHERE INC.
    • ILLUMINA
    • LI-COR BIOSCIENCES
    • LUCIGEN CORPORATION
    • MAXIM BIOTECH, INC.
    • NANOGEN, INC.
    • PROMEGA CORPORATION
    • QIAGEN, INC.
    • SEQUETECH CORPORATION
    • VISIGEN BIOTECHNOLOGIES, INC.
    • DNA LANDMARKS, INC.
    • ROCHE DIAGNOSTICS (A DIVISION OF F.HOFFMANN-LA ROCHE LIMITED)
    • SPARTAN BIOSCIENCE INC.
    • THERMO FISHER SCIENTIFIC, INC.
    • GENSCRIPT USA INC.
    • EUROGENTEC
  • EUROPE
    • EPPENDORF AG
    • EUROFINS MEDIGENOMIX GMBH
    • FEBIT HOLDING GMBH
    • GENEART AG
    • CYTOCELL, LTD.
    • SHIMADZU BIOTECH
    • SACACE BIOTECHNOLOGIES S.R.L.
    • DNAVISION SA
    • EXIQON
    • BIOTAGE AB
    • LIGHTUP TECHNOLOGIES AB
    • MICROSYNTH AG
  • ASIA-PACIFIC
    • HOKKAIDO SYSTEM SCIENCE CO., LTD.
    • OCIMUM BIOSOLUTIONS LTD.
    • AGRIGEN BIOTECH PTY LTD.
    • GENEWORKS PTY LTD.
    • SATURN BIOTECH LIMITED
    • TAKARA BIO, INC.
  • REST OF WORLD
    • HY LABORATORIES LTD.
    • INQABA BIOTECHNICAL INDUSTRIES (PTY) LTD.
Back to Top